"Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy"
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Hysteroscopic Myomectomy.
- Who it may be relevant to
- Registry conditions: LAZMAR Scoring , Hysteroscopic Myomectomy. Basic parameters: 18 years — 45 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Evaluating The Applicability of LASMAR Scoring in Predicting Surgical Outcomes Of Hysteroscopic Myomectomy"
Overview
This study aims to evaluate the applicability of the LASMAR scoring system, derived from hysteroscopy, in predicting surgical outcomes in patients undergoing hysteroscopic myomectomy for submucous fibroids.
Detailed description
This study aims to evaluate the applicability of LASMAR scoring in predicting surgical outcomes for cases of hysteroscopic myomectomy. By applying the LASMAR scoring system to patient , the study seeks to determine if the scoring can accurately predict operative time, completeness of resection, and complication rates.
Interventions
- Procedure Hysteroscopic Myomectomy
Hysteroscopic myomectomy is a minimally invasive surgical procedure used to remove fibroids that are located inside the uterine cavity (submucosal fibroids).
Primary outcome measures
- Correlation between preoperative parameters assessed using the Lasmar score and operative parameters, including operative time, number of sessions needed for complete resection, fluid deficit and intraoperative complications. [Time frame: 2 years]
Secondary outcome measures (2)
- Postoperative Complications: Including infection, adhesions, volume overload. [Time frame: 2 years]
- Need for Further Interventions: Incidence of additional treatments like hormonal therapy [Time frame: 2 years]
Eligibility criteria
Inclusion criteria
- Women aged 18-45 years
- Type 0,1,2 Fibroids according to Figo classification.
- Symptomatic submucous fibroids: Symptoms include abnormal uterine bleeding, pelvic pain or pressure symptoms, infertility or recurrent pregnancy loss.
- Fibroids size ≤ 5 cm in diameter
- Confirmed diagnosis of leiomyoma by ultrasound .
- Hemodynamically Stable Patients: Patients with no significant anemia.
Exclusion criteria
- Contraindications to hysteroscopy (e.g., Pregnancy, pyometra, active infection)
- Individuals with significant comorbidities (e.g., severe cardiovascular or respiratory diseases, bleeding diathesis).
- Cases requiring concurrent procedures (e.g., Laparoscopic surgeries).
- Fibroid Size>5 cm.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07578246 · OBGYN-HYST-2026-01